Craft

Therapeutic Solutions International

Stock Price

$0

2024-10-29

Market Capitalization

$3.7 M

2024-10-29

Revenue

$99 K

FY, 2023

Therapeutic Solutions International Summary

Company Summary

Overview
Therapeutic Solutions International focuses on immune modulation for the treatment of various diseases. The Company develops a range of immune-modulatory agents to target various cancers, enhance maternal and fetal health, and fight periodontal disease, as well as for daily health. Its flagship product is ProJuvenol, a synergistic blend of anti-aging ingredients based upon pterostilbene to promote cellular rejuvenation and healthy functionality.
Type
Public
Status
Active
Founded
2007
HQ
Oceanside, CA, US | view all locations
Website
http://therapeuticsolutionsint.com/
Cybersecurity rating
Sectors

Key People

  • Timothy G. Dixon, President, CEO, & Chairman

    • Thomas E.ichim, Director

      • Famela Ramos, Vice President Business Development

        • James Veltmeyer, Chief Medical Officer

          LocationsView all

          1 location detected

          • Oceanside, CA HQ

            United States

            4093 Oceanside Blvd

          Therapeutic Solutions International Financials

          Summary Financials

          Revenue (Q3, 2024)
          $19.7K
          Gross profit (Q3, 2024)
          $15.3K
          Net income (Q3, 2024)
          ($2.0M)
          Cash (Q3, 2024)
          $9.2K
          EBIT (Q3, 2024)
          ($2.0M)
          Enterprise value
          $3.8M

          Footer menu